Publications & Presentations

Jump To:

ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.

Recent Presentations

MOST RECENT PRESENTATION
May 2018

Alliance for Regenerative Medicine Policy Lunch

Washington, DC
March 1, 2018

ARM Advanced Therapies Summit

January 1, 2018

ARM 2018 Cell & Gene Therapy State of the Industry

Recent Publications

MOST RECENT PUBLICATION
July 2018
In Vivo Article

Moving From Chronic Therapies To Cures – Creating A Pathway To Enable New Payment Models

March 14, 2018
ARM Position Paper
January 1, 2018
Journal of Managed Care Medicine

Recent Webinars

MOST RECENT WEBINAR
June 2018

RMAT Designation – Impact on Regenerative Medicine Sector

Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording. Held in partnership with the Alliance for Regenerative Medicine (ARM), ARM, Informa Pharma Intelligence, and representative from Abeona, Athersys, and Enzyvant discuss the RMAT designation and its implications on the sector.

May 9, 2018
October 24, 2017

Recently Submitted Comments, Letters, Statements

August 2018

July 2018

June 2018

March 2018

February 2018